ACBD5-deficient patients typically exhibit a 1.2-fold elevation of VLCFA over healthy individuals, while X-ALD patients exhibit an average of 4.5-fold elevation (Moser et al., 1999). The gene discussed is ACBD5; the disease is adrenoleukodystrophy.